| scholarly article | Q13442814 |
| P2093 | author name string | Song Liu | |
| P2860 | cites work | Affective Disorders and Suicide Risk: A Reexamination | Q22306288 |
| The neuronal transporter gene SLC6A15 confers risk to major depression | Q24617186 | ||
| Prevalence of Depression and Depressive Symptoms Among Resident Physicians: A Systematic Review and Meta-analysis | Q26773436 | ||
| A Call for Systematic Research on Solute Carriers | Q26800313 | ||
| Neuroimmune mechanisms of depression | Q28084450 | ||
| Increased ventricular cerebrospinal fluid lactate in depressed adolescents | Q28834690 | ||
| NMDAR inhibition-independent antidepressant actions of ketamine metabolites. | Q30370600 | ||
| Reactome pathway analysis: a high-performance in-memory approach | Q30491025 | ||
| Global brain gene expression analysis links glutamatergic and GABAergic alterations to suicide and major depression | Q33492323 | ||
| Altered expression of glutamate signaling, growth factor, and glia genes in the locus coeruleus of patients with major depression | Q33553152 | ||
| The potential biomarker panels for identification of Major Depressive Disorder (MDD) patients with and without early life stress (ELS) by metabonomic analysis | Q33679513 | ||
| Novel urinary metabolite signature for diagnosing postpartum depression | Q33704082 | ||
| Evidence of altered polyamine concentrations in cerebral cortex of suicide completers | Q33868443 | ||
| Altered KYN/TRP, Gln/Glu, and Met/methionine sulfoxide ratios in the blood plasma of medication-free patients with major depressive disorder | Q33884852 | ||
| Prevalence of Depression in the Community from 30 Countries between 1994 and 2014. | Q49882507 | ||
| Investing in global mental health: the time for action is now. | Q50532204 | ||
| The Reactome Pathway Knowledgebase. | Q52433690 | ||
| The neuroactive potential of the human gut microbiota in quality of life and depression | Q63589897 | ||
| The Glutamine Transporters and Their Role in the Glutamate/GABA-Glutamine Cycle | Q88840602 | ||
| Antidepressant efficacy of a selective organic cation transporter blocker in a mouse model of depression | Q90754624 | ||
| Role of copper in depression. Relationship with ketamine treatment | Q91025364 | ||
| The SLC transporter in nutrient and metabolic sensing, regulation, and drug development | Q91619910 | ||
| Antidepressant-relevant concentrations of the ketamine metabolite (2R,6R)-hydroxynorketamine do not block NMDA receptor function | Q91843765 | ||
| Creatine for the Treatment of Depression | Q92876206 | ||
| [Discovering potential biomarkers of depression and drug intervention of paroxetine based on (1)H NMR metabolomics] | Q95572515 | ||
| Increased cerebrospinal fluid glutamine levels in depressed patients | Q33896467 | ||
| Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression | Q34084102 | ||
| Altered expression of synapse and glutamate related genes in post-mortem hippocampus of depressed subjects | Q34254887 | ||
| Confronting depression and suicide in physicians: a consensus statement | Q35157017 | ||
| Urinary metabonomics for diagnosis of depression in hepatitis B virus-infected patients | Q35645024 | ||
| Metabolomic differences in heart failure patients with and without major depression | Q35757760 | ||
| Metabolomic biosignature differentiates melancholic depressive patients from healthy controls | Q36109672 | ||
| Identification and validation of urinary metabolite biomarkers for major depressive disorder | Q36508139 | ||
| Connecting inflammation with glutamate agonism in suicidality. | Q36901111 | ||
| Reduced kynurenine pathway metabolism and cytokine expression in the prefrontal cortex of depressed individuals | Q37370987 | ||
| Increased ventricular lactate in chronic fatigue syndrome. III. Relationships to cortical glutathione and clinical symptoms implicate oxidative stress in disorder pathophysiology. | Q37494776 | ||
| Identification of sex-specific urinary biomarkers for major depressive disorder by combined application of NMR- and GC-MS-based metabonomics | Q37648213 | ||
| Risk factors for suicide in individuals with depression: a systematic review | Q38081627 | ||
| The Amino Acid Transporters of the Glutamate/GABA-Glutamine Cycle and Their Impact on Insulin and Glucagon Secretion | Q38178663 | ||
| Differential urinary metabolites related with the severity of major depressive disorder | Q38669894 | ||
| The role of inflammation in depression: from evolutionary imperative to modern treatment target | Q38681725 | ||
| Targeting glutamate signalling in depression: progress and prospects | Q38743867 | ||
| Discriminating poststroke depression from stroke by nuclear magnetic resonance spectroscopy-based metabonomic analysis | Q38830302 | ||
| Integrating neuroimmune systems in the neurobiology of depression. | Q38859380 | ||
| Controlled Interventions to Reduce Burnout in Physicians: A Systematic Review and Meta-analysis | Q39029499 | ||
| Depression and suicide among physician trainees: recommendations for a national response | Q41299411 | ||
| A novel urinary metabolite signature for diagnosing major depressive disorder | Q43827823 | ||
| Zinc transporters protein level in postmortem brain of depressed subjects and suicide victims. | Q45153786 | ||
| Special report: suicidal ideation among American surgeons. | Q45940476 | ||
| Health-related quality of life in depression: a STAR*D report. | Q46692665 | ||
| Predictive diagnosis of major depression using NMR-based metabolomics and least-squares support vector machine | Q47252364 | ||
| Plasma-metabolite-biomarkers for the therapeutic response in depressed patients by the traditional Chinese medicine formula Xiaoyaosan: A (1)H NMR-based metabolomics approach | Q47394787 | ||
| Study on suicide risk assessment in mental illness underestimates inpatient suicide risk | Q47593697 | ||
| Plasma metabolome analysis of patients with major depressive disorder | Q47650088 | ||
| Brain glutamate in medication-free depressed patients: a proton MRS study at 7 Tesla | Q47682835 | ||
| SNAT1 and a family with high rates of suicidal behavior. | Q47799492 | ||
| Quantitative proteomics analysis of the liver reveals immune regulation and lipid metabolism dysregulation in a mouse model of depression | Q48011904 | ||
| Prefrontal changes in the glutamate-glutamine cycle and neuronal/glial glutamate transporters in depression with and without suicide | Q48047692 | ||
| A Novel Urinary Metabolite Signature for Non-invasive Post-stroke Depression Diagnosis | Q48050618 | ||
| Increased pregenual anterior cingulate glucose and lactate concentrations in major depressive disorder | Q48055338 | ||
| Metabolite signature for diagnosing major depressive disorder in peripheral blood mononuclear cells | Q48064073 | ||
| A GC-MS urinary quantitative metabolomics analysis in depressed patients treated with TCM formula of Xiaoyaosan | Q48067014 | ||
| Plasma amino acid profiling in major depressive disorder treated with selective serotonin reuptake inhibitors. | Q48130319 | ||
| Measurement of brain metabolites in patients with type 2 diabetes and major depression using proton magnetic resonance spectroscopy | Q48332909 | ||
| A variant of the neuronal amino acid transporter SLC6A15 is associated with ACTH and cortisol responses and cognitive performance in unipolar depression. | Q48583559 | ||
| Plasma metabonomics as a novel diagnostic approach for major depressive disorder. | Q48760949 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P304 | page(s) | 269 | |
| P577 | publication date | 2020-04-16 | |
| P1433 | published in | Frontiers in Psychiatry | Q27723495 |
| P1476 | title | Metabonomic Profile and Signaling Pathway Prediction of Depression-Associated Suicidal Behavior | |
| P478 | volume | 11 |
Search more.